A comprehensive view of Cancer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
AstraZeneca ordered to pay US$107.5M to Pfizer for infringing two patents with its oncology med Tagrisso; Pfizer subsidiary Wyeth and Puma Biotechnology first sued AstraZeneca in 2021
Published:
May 20, 2024
by FiercePharma
|
AstraZeneca to pay $107.5M for cancer drug patent infringement
Published:
May 20, 2024
by Becker's Hospital Review
|
Regeneron Pharmaceuticals Submits Patent Application for Anti-FGFR3 Antibodies and Antigen-Binding Fragments and Methods of Use Thereof
Published:
May 19, 2024
by Pharmaceutical Patent News
|
INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "COMBINATION THERAPIES FOR THE TREATMENT OF CANCER"
Published:
May 19, 2024
by U.S. Fed News
|
FDA approves Amgen's Imdelltra as second or later line of treatment for advanced small-cell lung cancer patients; globally about 330,00 people are diagnosed with lung cancer every year, with about 35,000 patients living in the US
Published:
May 17, 2024
by Baystreet US News Alerts
|
Ask us about our Government & Public Policy market view